Current trends in development of HDAC-based chemotherapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current trends in development of HDAC-based chemotherapeutics

Published:2022-11 Issue: Volume:308 Page:120946
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Cheshmazar Narges,Hamzeh-Mivehroud Maryam,Nozad Charoudeh Hojjatollah,Hemmati Salar,Melesina Jelena,Dastmalchi Siavoush

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference71 articles.

1. A click chemistry approach reveals the chromatin-dependent histone H3K36 deacylase nature of SIRT7;Wang;J. Am. Chem. Soc.,2019

2. HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity;Karagiannis;Cancers,2021

3. Epigenetic regulation of post-embryonic development;Palli;Curr.Opin.Insect Sci.,2021

4. Discerning evolutionary trends in post-translational modification and the effect of intrinsic disorder: analysis of methylation, acetylation and ubiquitination sites in human proteins;Narasumani;PLoS Comput. Biol.,2018

5. Proteasomal degradation of Zn-dependent Hdacs: the E3-ligases implicated and the designed protacs that enable degradation;Márquez-Cantudo;Molecules,2021

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma;Oncology Reviews;2024-08-12

2. Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense;Frontiers in Immunology;2024-07-31

3. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design;Biochemical Pharmacology;2024-07

4. Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches;Frontiers in Pharmacology;2024-06-28

5. HDAC3 inhibitor RGFP966 mitigates acute kidney injury by modulating RIPK1-mediated programmed necrosis;2024-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3